HIMSS26: CIOs and CFOs Clash Over AI’s Elusive Return on Investment

The HIMSS26 Executive Summit has brought to the forefront a critical tension that defines the current era of digital transformation: the 'ROI Gap' between the Chief Information Officer (CIO) and the Chief Financial Officer (CFO). As artificial intelligence moves out of the experimental pilot phase and into the core operational budget, the debate has shifted from what the technology can do to what it actually saves. This friction is not merely a budgetary dispute but a fundamental disagreement on how value is defined in a post-pandemic healthcare economy characterized by razor-thin margins and chronic labor shortages.

For the CIO, the argument for AI is rooted in operational resilience and clinical quality. Technology leaders at the summit argued that AI is the only viable solution to the escalating clinician burnout crisis. By automating documentation, streamlining triage, and providing predictive analytics at the bedside, AI serves as a 'force multiplier' for a depleted workforce. From this perspective, the return on investment is often 'soft'—measured in terms of staff retention, patient safety, and long-term institutional agility. CIOs are increasingly frustrated by traditional accounting models that fail to capture the cost of inaction, arguing that failing to invest in AI today will lead to higher operational costs and competitive obsolescence tomorrow.

“

The HIMSS26 Executive Summit has brought to the forefront a critical tension that defines the current era of digital transformation: the 'ROI Gap' between the Chief Information Officer (CIO) and the Chief Financial Officer (CFO).

Conversely, CFOs are adopting a stance of 'AI skepticism' born from years of tech-driven promises that failed to materialize as bottom-line savings. At the summit, financial leaders emphasized that with interest rates remaining volatile and reimbursement rates stagnant, every dollar of capital must yield a measurable decrease in operating expenses or a clear increase in revenue. CFOs are looking for 'hard ROI,' such as a reduction in full-time equivalents (FTEs) in administrative departments, a decrease in denied claims, or a measurable uptick in bed turnover rates. The sentiment among finance executives is that the 'honeymoon phase' of AI experimentation is over; they are now demanding that AI vendors and internal IT teams provide 12-to-18-month payback periods, a standard that many clinical AI applications struggle to meet.